Content deleted Content added
No edit summary |
Keystone18 (talk | contribs) |
||
(13 intermediate revisions by 11 users not shown) | |||
Line 2:
{{Use dmy dates|date=November 2013}}
{{Infobox company
| name
| logo
| type
| foundation = {{Start date
| founder
| location
| parent
| key_people = *Kevin Kettler (Chairman of the Management Board/ Chief Operating Officer/ Labour Relations Director),▼
▲*Kevin Kettler (Chairman of the Management Board/ Chief Operating Officer/ Labour Relations Director),
* Brian S. Tyler ([[Chairman]] of the [[Supervisory Board]])
| industry
| services
| revenue
| num_employees = 36,917 (FY 2019)
| homepage
}}
[[File:McKesson Europe Head Office Stuttgart.jpg|thumb|McKesson Europe Head Office Stuttgart]]
'''McKesson Europe AG''' (formerly '''Celesio AG''', previously '''Gehe AG'''), with its headquarters in
==Overview==
Line 34 ⟶ 33:
===1835 - 1948===
The chemist and paint business Gehe & Co. was founded on 1 May 1835 by [[Franz Ludwig Gehe]] in [[Dresden]] on Königstraße<ref>[http://www.celesio.com/ag/?subnavid=0&ni=10-100&lg=de 1. Mai 1835: Unternehmensgründung]</ref> and opened to the [[capital market]] by converting it into a stock corporation on 1 January 1903. In January 1904, the shares were admitted to trading on the [[Exchange (organized market)|stock exchange]] in Dresden.<ref>[http://www.celesio.com/ag/?subnavid=2&ni=10-100&lg=de 1903–1947: Geschichte]</ref>
In 1909, the company moved to the new location on Leipziger Straße and the trading house in Königstraße was vacated. With [[Seasoned equity offering|capital increases]] in 1910 and 1912, the financial basis for the establishment and expansion of a German-wide distribution of "drugs and paints, pharmaceutical and chemical products" was created. In 1922, the company founded its first German branch in Stuttgart.
Line 47 ⟶ 46:
===From 2003===
In April 2003, the company celebrated its 100th year. On the birthday of the conversion into a [[joint-stock company]], the [[Annual general meeting|Annual General Meeting]] decided to change the name from Gehe AG to Celesio AG, with a majority of 99.98%. Today, the German subsidiary GEHE Pharma Handel still operates under its original name. In April 2007, Celesio announced the acquisition of 90% of the shares in the mail-order pharmacy [[:de:DocMorris|DocMorris]], in order to build up a pharmacy chain across Germany.<ref>26. April 2007 [http://www.finanznachrichten.de/nachrichten-2007-04/8136021-roundup-2-celesio-erwirbt-mehrheit-an-docmorris-apothekenkette-geplant-016.htm Celesio erwirbt Mehrheit an DocMorris]</ref> The acquisition took place in hopes that the [[:de:Apothekengesetz (Deutschland)#Fremdbesitzverbot|third-party ownership ban]] of the Pharmacies Act would fail, but it was legitimised in May 2009 by the [[European Court of Justice|EuGH]]. For the pharmaceutical wholesaler Gehe, which was also part of the Celesio Group, the acquisition resulted in a loss of customers as pharmacists saw a threat in the chain. DocMorris was now operated as a franchise-like concept, in which pharmacists were allowed to use the DocMorris brand with the payment of a monthly licence fee. As a result, Celesio sold DocMorris in October 2012 to the company [[
In June 2009, it became known that Celesio had acquired the majority of the largest Brazilian pharmaceutical wholesaler, Panpharma. In April 2012, Panpharma was fully taken over. In February 2016, Celesio agreed to sell its Brazilian business, consisting of Panpharma and Oncoprod, to the holding of the Brazilian pharmaceutical wholesaler, SantaCruz. In September 2013, Celesio sold its subsidiary, Rudolf Spiegel GmbH, to the company WEPA Apothekenbedarf.
On 24 October 2013, the US-based [[McKesson Corporation
[[Sainsbury’s]] and Celesio announced the formation of a strategic pharmacy partnership in July 2013, in the course of which McKesson Europe's subsidiary LloydsPharmacy would acquire Sainsbury’s pharmacy business for GBP 125 million.
Until 21 September 2015, the company's shares were listed in [[MDAX]]. The quotation in the index was removed, due to the change in the stock exchange segment from [[Prime Standard]] to the [[:de:Freiverkehr|Regulated Unofficial Market]]. On 12 September 2017, Celesio was renamed McKesson Europe.
On 12 December 2019, McKesson Corporation announced that it planned to bring its German wholesale business (GEHE Pharma Handel GmbH, a subsidiary of McKesson Europe) into a joint venture with Alliance Healthcare Deutschland AG (a subsidiary of Walgreens Boots Alliance). McKesson should hold 30% of the planned joint venture, Walgreens Boots Alliance 70%.<ref>{{cite web|title=Alliance Healthcare und Gehe vereinbaren Zusammenarbeit|periodical=|publisher=|url=https://www.deutsche-apotheker-zeitung.de/news/artikel/2019/12/12/mckesson-und-alliance-healthcare-vereinbaren-zusammenarbeit|url-status=|format=|access-date=2020-01-15|archive-url=|archive-date=|last=Benjamin Rohrer|date=2019-12-12|year=|language=|pages=|quote=}}</ref>
===Management Board===
* Kevin Kettler (
* Tilo Köster (Member of the Board, Law and Compliance, since 23 September 2014)
* Alain Vachon (Member of the Board, Finance, since 16 July 2014).
Line 80 ⟶ 79:
==References==
{{
==External links==
Line 86 ⟶ 85:
* {{PM20|FID=co/009665|TEXT=Documents and clippings about|NAME=Gehe & Co}}
{{
[[Category:Companies based in Stuttgart]]
Line 94 ⟶ 93:
[[Category:Companies established in 1835]]
[[Category:Medical and health organisations based in Baden-Württemberg]]
[[Category:McKesson Corporation]]
|